Skip to main content
Pakistan Journal of Medical Sciences logoLink to Pakistan Journal of Medical Sciences
. 2023 May-Jun;39(3):804–808. doi: 10.12669/pjms.39.3.7248

Quantitative evaluation of acute myocardial infarction by feature-tracking cardiac magnetic resonance imaging

Jun Ye 1, Wenxia Zong 2, Xing Wu 3, Xiaonan Shao 4, Yue Wu 5,
PMCID: PMC10214789  PMID: 37250547

Abstract

Objective:

To assess the value of feature-tracking cardiac magnetic resonance (FT-CMR) imaging in the quantitative evaluation of acute myocardial infarction (AMI).

Methods:

We retrospectively analyzed medical records of patients with acute myocardial infarction (AMI) diagnosed in the Department of Cardiology of Hubei No.3 People’s Hospital of Jianghan University from April 2020 to April 2022, who underwent feature-tracking cardiac magnetic resonance (FT-CMR) examination. Based on the electrocardiogram (ECG) findings, patients were divided into ST-elevation myocardial infarction (STEMI) (n=52) and non-STEMI (NSTEMI) (n=48) groups. We compared myocardial strain parameters between the two groups and applied the Pearson’s test to reveal any correlations between the left ventricular myocardial strain parameters and the number of late gadolinium enhancement (LGE) positive segments; we assessed the clinical value of FT-CMR for predicting STEMI using a receiver operating characteristic (ROC) curve.

Results:

The number of LGE-positive segments in the STEMI group was significantly higher than that in the NSTEMI group. The myocardial radial, circumferential and longitudinal strains in the STEMI group were significantly lower than those in the NSTEMI group (p<0.05). The number of LGE-positive segments in patients with AMI negatively correlated with the radial, circumferential and longitudinal strains. The results of the ROC curve analysis showed that radial, circumferential and longitudinal strain values have a diagnostic value for STEMI (p<0.05).

Conclusion:

FT-CMR, a non-invasive and rapid method for analyzing myocardial strains, has a high diagnostic value for AMI and should be helpful for the prevention and intervention of ventricular remodeling after myocardial infarctions.

KEYWORDS: Feature-tracking cardiac magnetic resonance, Acute myocardial infarction, ST-elevation myocardial infarction, Late gadolinium enhancement

INTRODUCTION

The main pathological changes in acute myocardial infarction (AMI) are acute myocardial ischemia and necrosis.1 AMIs can be divided into ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) according to ECG findings.2 Both syndromes are caused by severe coronary artery stenosis or complete occlusion (mainly due to thrombosis on atherosclerotic plaques), and have similar clinical manifestations.3 Although clinically similar, these conditions differ in the severity of complications, treatment and prognosis.4 Therefore, accurate diagnosis of STEMI and NSTEMI is crucial.

Cardiac magnetic resonance (CMR), a non-invasive and radiation-free imaging technology, has become the gold standard for the measurement of cardiac parameters, and feature-tracking cardiac magnetic resonance (FT-CMR) is often used to measure cardiac structures and function (coronary artery imaging, ventricular wall motion, hemodynamics, myocardial activity, etc.).5-7 However, predicting myocardial damage and three-dimensional functional changes of cardiac stress in STEMI patients in advance is impossible.8 FT-CMR imaging has been frequently used to detect cardiac stress.9 Relevant studies have confirmed that this technology based on a steady-state free precession (SSFP) film sequence of magnetic resonances has a high clinical diagnostic value in cases of severe aortic stenosis, cardiac amyloidosis, heart failure, arrhythmogenic right ventricular dysplasia, cardiomyopathy and other heart diseases.10,11 However, the reports about the predictive ability of FT-CMR in STEMI are scarce. Therefore, we reviewed the FT-CMR imaging data of patients with AMI, analyzing the correlation between FT-CMR myocardial strain parameters and STEMI, and assessed the predictive ability of FT-CMR for STEMI.

METHODS

We selected the records of one hundred patients (54 men and 46 women) with AMI diagnosed in the Department of Cardiology of Hubei No.3 People’s Hospital of Jianghan University from April 2020 to April 2022 who underwent FT-CMR examinations. Patients were continuously monitored by electrocardiogram to observe changes in heart rate, heart rhythm, blood pressure, and respiration, and venous access was established soon after admission. Drug and reperfusion therapy were performed according to the patients’ conditions. The disease course ranged from three to six years with an average of 4.46 ± 0.68 years. All the patients received coronary angiography and percutaneous coronary intervention, followed by FT-CMR. The median door-to-ECG, artery access and balloon times were 19 minutes, 84 minutes and 118 minutes, respectively. The average age of the patients was 65.88 ± 8.56 years. The mean left ventricular ejection fraction (LVEF) was 42.56 ± 6.98%. According to ECG records, we had 52 patients with STEMI in the STEMI group, and 48 patients without STEMI in the NSTEMI group. We counted 365 LGE-positive segments of which 251 were detected in the STEMI group and 114 in the NSTEMI group.

Inclusion criteria:

  • Age≥18 years

  • Patients with AMI diagnosed by coronary angiography or CT angiography according to the relevant diagnostic criteria formulated by the Chinese Society of Cardiology of Chinese Medical Association:12 1) Elevated serum levels of cardiac isoenzymes or troponin; 2) Persistent chest pain that lasts ≥ 30 minutes and unresponsive to nitroglycerin; 3) ST-segment elevation on electrocardiogram (ECG)

  • Patients received FT-CMR examination within one month after AMI onset

  • Patients with complete and continuous cardiac imaging data

Exclusion criteria:

  • Presence of other heart diseases, such as heart valve disease, congenital heart disease, cardiomyopathy, or severe arrhythmia

  • Severe metabolic diseases of the lungs, liver or kidneys

  • Presence of autoimmune diseases

  • Patients complicated with cardiac rupture, ventricular wall tumor, appendage thrombosis, heart failure and cardiogenic shock

  • Patients who have experienced cardiac arrest

Ethical Approval:

This study was approved by the medical ethics committee of Hubei No.3 People’s Hospital of Jianghan University (approval number, 2021003; 24th of May, 2021)

Inspection method:

Scanner: We used a 3Tesla MRI Scanner (Discovery MR750; GE Healthcare, Milwaukee, USA) with a steady-state free precession (SSFP) cine sequence, 8-Channel cardiac phased coil, and MR compatible ECG gating and respiratory gating board. Scanning methods: 1) We performed axial, coronal and sagittal localization scans with the patient in a supine position. 2) The long axial plane of the left ventricular two-chamber heart and four chamber heart, and the short axial plane of left ventricle were determined on the basis of the standard axial plane. 3) The images were collected to obtain the SSFP film sequence of each section at the end of an expiration.

We set the following acquisition parameters13-15: setting - turning angle (47.5° ± 2.5), visual field (36.0 cm × 38.0 cm), echo time (1.6 ± 0.1 ms), repetition time (3.2 ± 0.25 ms), and the specified scanning acquisition layer thickness (8 mm). We applied the sensitivity reversion method to measure the two-chamber center, the four-chamber center and the short-axis cavity after 10 to 15 minutes. The imaging parameters considered included the visual field (36.0 cm × 38.0 cm), the repetition time (4.1 -4.2 ms), the echo time fixed (1.6 ms), the specified layer thickness (0.80 cm), the total imaging scanning (8-10 layers), and the set reversal time (300 ms). 4) For the delayed enhancement scan we applied an intravenous injection of gadopentetate dimeglumine (Bayer, Germany; specification: 469.01 mg/ml × 15 ml; approval number: J20080046), the dose was 0.2 mmol/kg, the injection rate 4.0 mL/s, and the same amount of 0.9% sodium chloride was injected at the same rate. After the intravenous injection of contrast agent for 10 minutes, the scanner set with sensitivity inversion recovery sequence took LGE images of short axis, two chamber heart, four chamber heart and left ventricular inflow and outflow tract.

Image processing scheme:13

A senior radiologist with a CMR certification blinded to the patient’s condition performed the imaging examination and interpretation of the results. According to the SSFP sequence, the FT-CMR machine generates short axis movies of the two-chamber heart and four-chamber heart and transmits all images to the CVI42 software (circle cardiovascular imaging, Calgary, Canada); the complete cardiac cycle is thus outlined. The left ventricular ejection fraction (LVEF) and myocardial strain parameters (including radial strain, circumferential strain, longitudinal strain, and others) were obtained using the relative movement and displacement of the left ventricular endocardium and the upper edge of the epicardium. The radial strain, circumferential strain, longitudinal strain, and other indexes are compared in absolute values (positive values indicate myocardial lengthening and thickening, negative values indicate myocardial shortening and thinning). Global left ventricular deformation force: for the strain analysis of left ventricular short axis (Fig.1 and long axis view (Fig.2). We divided the left ventricle into 16 segments for evaluation following the American Heart Association standard.16 We defined the LGE-positive segment (myocardial infarction segment) as one with a signal intensity larger than five standard deviations from the distal normal myocardium at the same level.

Fig.1.

Fig.1

Left ventricular short axis position.

Fig.2.

Fig.2

Left ventricular long axis position.

Statistical Analysis:

We used the SPSS 22.0 software to analyze the data. The measurement data were expressed as mean and standard deviations (χ̅±S), we applied independent sample t-tests for comparisons between groups; count data were expressed as numbers (percentages %), and Chi squared tests were used for comparisons between groups. Pearson’s correlation analyses were used to analyze correlations between the strain values of the left ventricular myocardium and the number of LGE-positive segments. The clinical value of myocardial strain parameters in the diagnosis of STEMI was assessed by analyzing the working characteristics of subjects (in ROC curve).

RESULTS

A total of one hundred patients diagnosed with AMI were included in this study. In the STEMI group, there were 52 patients (mean [SD] age, 65.13 [8.03] years), 32 (61.54%) males and 20 (38.46%) females; in the NSTEMI group, there were 48 patients (mean [SD] age, 65.87 [8.32] years), 26 (54.17%) males and 22 (45.83%) females. We found similar numbers of cases, ages, sex ratios, disease courses and LVEFs between the two groups (p>0.05). However, the number of LGE-positive segments in the STEMI group was significantly higher than that in NSTEMI group (p<0.05) (Table-I). The radial, circumferential and longitudinal strains of the STEMI group were significantly lower than those of the NSTEMI group (p<0.05) (Table-II).

Table-I.

Comparison of clinical baseline data between the two groups.

Group n Male/Female Age (years) Course of disease (years) LVEF/% LGE positive segments
STEMI-Group 52 32/20 65.13±8.03 4.53±0.70 41.35±6.39 4.83±1.08
NSTEMI-Group 48 26/22 65.87±8.32 4.62±0.79 42.13±6.79 2.37±0.89
χ2/t 0.557 0.452 0.582 0.596 12.332
p-Value 0.456 0.652 0.562 0.553 <0.001

Table-II.

Comparison of left ventricular myocardial strain parameters between the two groups.

Group n Radial strain (%) Circumferential strain (%) Longitudinal strain (%)
STEMI-Group 52 17.07±6.39 -8.70±2.62 -7.58±1.82
NSTEMI-Group 48 21.25±6.61 -12.52±3.33 -11.36±4.07
T 3.217 6.328 6.063
p-Value 0.002 <0.001 <0.001

The number of LGE-positive segments in patients with AMI negatively correlated with the radial, circumferential, and longitudinal strains (p<0.05) (Table-III) ROC curve analysis showed that the radial strain, circumferential strain and longitudinal strain of left ventricular myocardium had diagnostic value for STEMI (p<0.05) (Table-IV) and Fig.3.

Table-III.

Pearson test for correlation between myocardial strain parameters and LGE in AMI.

Strain r-Value p-Value
Radial strain (%) -0.263 0.008
Circumferential strain (%) -0.313 0.002
Longitudinal strain (%) -0.450 <0.001

Table-IV.

ROC curve parameters of CMR-FT for predicting clinical value of STEMI.

Strain AUC Sensitivity Specificity 95% CI p-Value Cut-off Value
Radial strain (%) 0.677 98.10% 12.70% 0.572~0.783 <0.001 28.89%
Circumferential strain (%) 0.866 94.20% 52.50% 0.797~0.935 <0.001 -13.27%
Longitudinal strain (%) 0.788 96.20% 44.10% 0.699~0.877 <0.001 -10.79%

Fig.3.

Fig.3

ROC curve of CMR-FT in predicting clinical value of STEMI.

DISCUSSION

This study analyzed the diagnostic efficacy of FT-CMR and related post-processing techniques for STEMI in patients with AMI. Our results show that the number of LGE-positive segments of the STEMI group was significantly higher than that of the NSTEMI group, indicating that the infarcted area in patients with STEMI was significantly higher than that of patients with NSTEMI, which is consistent with the findings of Dong et al.17 FT-CMR can determine whether a stenosis focus is present in different levels of blood vessels, and it can help locate the lesion, its scope, severity and vascular wall stenosis condition, providing a basis for the formulation of an operation plan.18 Dannenberg V et al.19 conducted an FT-CMR evaluation on 70 patients with STEMI, their results showed that the left ventricular strain parameters are significantly correlated with the risk area and infarct area measured by CMR. In addition, Schuster A et al.20 in a meta-analysis study involving 1235 patients with AMI showed that the left atrium peak reservoir strain obtained by FT-CMR has a high prognostic value for predicting major adverse cardiovascular events.

Our results show that the radial, circumferential and longitudinal strains of the left ventricular myocardium in patients with STEMI were significantly lower than those in patients with NSTEMI (p<0.001). This suggests that the epicardial myocardial ischemia injury in patients with STEMI is more serious than that in patients with NSTEMI, a finding consistent with the pathological characteristics of STEMI myocardial infarction involving the whole myocardium.21 FT-CMR technology reveals the myocardial strain parameters through post-processing with the strain as a vector, its positive value indicates myocardial lengthening and thickening, and its negative value indicates myocardial shortening and thinning; myocardial strain parameters can quantitatively evaluate myocardial length changes.22 Neisius U et al.23 used FT-CMR to detect myocardial deformations in 244 consecutive patients and were able to distinguish between hypertensive heart disease and hypertrophic cardiomyopathy. Lai W et al.24 studied early CMR myocardial tissue characteristics in 420 patients with first-time STEMI and in 40 patients without obvious heart disease (the control group). Their results showed that the strain values of left and right ventricles in patients with STEMI were significantly lower than those in controls. Our results are consistent with these studies, although we did not observe myocardial strain changes in the right ventricle of the patients with STEMI (a shortcoming of this study). A consistency test for STEMI and LGE-positive segments showed a correlation in patients with AMI. Podlesnikar T et al.25 used FT-CMR to evaluate 191 patients one week and six months after STEMI, and showed that the left ventricular infarct area was closely associated with the myocardial strain. Further, ROC curve evaluation showed that the circumferential and longitudinal strains have a high diagnostic value for STEMI (the radial strain has a general diagnostic value). The clinical research results of Bratis K et al.26 also showed that in asymptomatic patients with systemic sclerosis and normal routine functional indexes, FT-CMR can identify subclinical insertion fibrosis and/or myocardial infarction based on the left ventricular longitudinal strain damage. These results suggest that during the early stages of myocardial infarction, an FT-CMR film sequence examination without contrast agent, combined with myocardial strain measurements, can help clinicians to quickly identify chest pain causes, predict whether patients with AMI have STEMI, reveal the infarct scope and the arteries involved, provide imaging support to prevent adverse cardiovascular events, avoid reception delays, and reduce the incidence of adverse clinical prognoses.24-26

Limitations:

Our study was mainly a retrospective case-control study with a small sample size, without in-depth studies on the impact of FT-CMR on LGE negative sites or the number and location of culprit vessels in patients with STEMI. In addition, we did not assess the impact of baseline data such as age or gender, and we did not analyze the peak strain in each direction during systole. The patients in this study had inevitably taken therapeutic drugs, such as anticoagulants, before we collected the images, and that may have altered the study results. Our survey presented data deviations and our conclusions are subjective. Multi-center RCT studies with large sample sizes are needed to explore and confirm our findings.

CONCLUSION

FT-CMR is a non-invasive and rapid method for analyzing myocardial strain. It has high diagnostic value for AMI and is helpful for the prevention and intervention of ventricular remodeling after myocardial infarctions.

Authors’ contributions:

JY conceived and designed the study.

WZ, XW, XS and YW collected the data and performed the statistical analysis.

JY prepared the manuscript and is responsible for the integrity of study.

All authors have read and approved the final manuscript.

REFERENCES

  • 1.Tang X, Li R, Ma L, Zhang T. Application of tirofiban in patients with acute myocardial infarction complicated with diabetes and undergoing emergency interventional therapy. Pak J Med Sci. 2022;38(1):172–178. doi: 10.12669/pjms.38.1.4545. doi:10.12669/pjms.38.1.4545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mitsis A, Gragnano F. Myocardial Infarction with and without ST-segment Elevation:a Contemporary Reappraisal of Similarities and Differences. Curr Cardiol Rev. 2021;17(4):e230421189013. doi: 10.2174/1573403X16999201210195702. doi:10.2174/1573403X16999201210195702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Khan MA, Khawaja MN, Hakeem F. Predicting clinical outcome in diabetics vs. non diabetics with acute myocardial infarction after thrombolysis, using ECG as a tool. J Pak Med Assoc. 2011;61(10):1032–1037. [PubMed] [Google Scholar]
  • 4.Miyachi H, Takagi A, Miyauchi K, Yamasaki M, Tanaka H, Yoshikawa M, et al. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area:from the Tokyo CCU network registered cohort. Heart Vessels. 2016;31(11):1740–1751. doi: 10.1007/s00380-015-0791-9. doi:10.1007/s00380-015-0791-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update :Society for Cardiovascular Magnetic Resonance (SCMR):Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson. 2020;22(1):19. doi: 10.1186/s12968-020-00610-6. doi:10.1186/s12968-020-00610-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Schuster A, Hor KN, Kowallick JT, Beerbaum P, Kutty S. Cardiovascular Magnetic Resonance Myocardial Feature Tracking:Concepts and Clinical Applications. Circ Cardiovasc Imaging. 2016;9(4):e004077. doi: 10.1161/CIRCIMAGING.115.004077. doi:10.1161/CIRCIMAGING.115.004077. [DOI] [PubMed] [Google Scholar]
  • 7.Gannon MP, Schaub E, Grines CL, Saba SG. State of the art:Evaluation and prognostication of myocarditis using cardiac MRI. J Magn Reson Imaging. 2019;49(7):e122–e131. doi: 10.1002/jmri.26611. doi:10.1002/jmri.26611. [DOI] [PubMed] [Google Scholar]
  • 8.Beijnink CWH, van der Hoeven NW, Konijnenberg LSF, Kim RJ, Bekkers SCAM, Kloner RA, et al. Cardiac MRI to Visualize Myocardial Damage after ST-Segment Elevation Myocardial Infarction:A Review of Its Histologic Validation. Radiology. 2021;301(1):4–18. doi: 10.1148/radiol.2021204265. doi:10.1148/radiol.2021204265. [DOI] [PubMed] [Google Scholar]
  • 9.Bing R, Cavalcante JL, Everett RJ, Clavel MA, Newby DE, Dweck MR. Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis. JACC Cardiovasc Imaging. 2019;12(2):283–296. doi: 10.1016/j.jcmg.2018.11.026. doi:10.1016/j.jcmg.2018.11.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kholmovski EG, Morris AK, Chelu MG. Cardiac MRI and Fibrosis Quantification. Card Electrophysiol Clin. 2019;11(3):537–549. doi: 10.1016/j.ccep.2019.04.005. doi:10.1016/j.ccep.2019.04.005. [DOI] [PubMed] [Google Scholar]
  • 11.Pontecorboli G, Figueras I Ventura RM, Carlosena A, Benito E, Prat-Gonzales S, Padeletti L, et al. Use of delayed-enhancement magnetic resonance imaging for fibrosis detection in the atria:a review. Europace. 2017;19(2):180–189. doi: 10.1093/europace/euw053. doi:10.1093/europace/euw053. [DOI] [PubMed] [Google Scholar]
  • 12.Chinese Society of Cardiology of Chinese Medical Association;Editorial Board of Chinese Journal of Cardiology. Zhonghua Xin Xue Guan Bing Za Zhi. 2019;47(10):766–783. doi: 10.3760/cma.j.issn.0253-3758.2019.10.003. doi:10.3760/cma.j.issn.0253-3758.2019.10.003. [DOI] [PubMed] [Google Scholar]
  • 13.Ito H, Ishida M, Makino W, Goto Y, Ichikawa Y, Kitagawa K, et al. Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction:correlation of global longitudinal strain with invasive diastolic functional indices. J Cardiovasc Magn Reson. 2020;22(1):42. doi: 10.1186/s12968-020-00636-w. doi:10.1186/s12968-020-00636-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bratis K, Lindholm A, Hesselstrand R, Arheden H, Karabela G, Stavropoulos E, et al. CMR feature tracking in cardiac asymptomatic systemic sclerosis:Clinical implications. PLoS One. 2019;14(8):e0221021. doi: 10.1371/journal.pone.0221021. doi:10.1371/journal.pone.0221021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yu S, Zhou J, Yang K, Chen X, Zheng Y, Zhao K, et al. Correlation of Myocardial Strain and Late Gadolinium Enhancement by Cardiac Magnetic Resonance After a First Anterior ST-Segment Elevation Myocardial Infarction. Front Cardiovasc Med. 2021;8:705487. doi: 10.3389/fcvm.2021.705487. doi:10.3389/fcvm.2021.705487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mehta A, Mahtta D, Gulati M, Sperling LS, Blumenthal RS, Virani SS. Cardiovascular Disease Prevention in Focus:Highlights from the 2019 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2020;22(1):3. doi: 10.1007/s11883-020-0822-6. doi:10.1007/s11883-020-0822-6. [DOI] [PubMed] [Google Scholar]
  • 17.Dong S, Liu Y, Sun W, Wang C, Wang Y, Zhao W, et al. Analysis of Characteristics of Patients with Non-ST-Segment Elevation Myocardial Infarction by Cardiac Magnetic Resonance Imaging. Med Sci Monit. 2021;27:e933220. doi: 10.12659/MSM.933220. doi:10.12659/MSM.933220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Muser D, Castro SA, Santangeli P, Nucifora G. Clinical applications of feature-tracking cardiac magnetic resonance imaging. World J Cardiol. 2018;10(11):210–221. doi: 10.4330/wjc.v10.i11.210. doi:10.4330/wjc.v10.i11.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dannenberg V, Christiansen F, Schneider M, Kastl S, Hofbauer TM, Scherz T, et al. Exploratory echocardiographic strain parameters for the estimation of myocardial infarct size in ST-elevation myocardial infarction. Clin Cardiol. 2021;44(7):925–931. doi: 10.1002/clc.23608. doi:10.1002/clc.23608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Schuster A, Backhaus SJ, Stiermaier T, Navarra JL, Uhlig J, Rommel KP, et al. Left Atrial Function with MRI Enables Prediction of Cardiovascular Events after Myocardial Infarction:Insights from the AIDA STEMI and TATORT NSTEMI Trials. Radiology. 2019;293(2):292–302. doi: 10.1148/radiol.2019190559. doi:10.1148/radiol.2019190559. [DOI] [PubMed] [Google Scholar]
  • 21.Kapur NK, Alkhouli MA, DeMartini TJ, Faraz H, George ZH, Goodwin MJ, et al. Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction. Circulation. 2019;139(3):337–346. doi: 10.1161/CIRCULATIONAHA.118.038269. doi:10.1161/CIRCULATIONAHA.118.038269. [DOI] [PubMed] [Google Scholar]
  • 22.Almutairi HM, Boubertakh R, Miquel ME, Petersen SE. Myocardial deformation assessment using cardiovascular magnetic resonance-feature tracking technique. Br J Radiol. 2017;90(1080):20170072. doi: 10.1259/bjr.20170072. doi:10.1259/bjr.20170072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Neisius U, Myerson L, Fahmy AS, Nakamori S, El-Rewaidy H, Joshi G, et al. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy. PLoS One. 2019;14(8):e0221061. doi: 10.1371/journal.pone.0221061. doi:10.1371/journal.pone.0221061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lai W, Jie H, Jian-Xun D, Ling-Cong K, Jun-Tong Z, Bo-Zhong S, et al. Impact of Concomitant Impairments of the Left and Right Ventricular Myocardial Strain on the Prognoses of Patients With ST-Elevation Myocardial Infarction. Front Cardiovasc Med. 2021;8:659364. doi: 10.3389/fcvm.2021.659364. doi:10.3389/fcvm.2021.659364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Podlesnikar T, Pizarro G, Fernández-Jiménez R, Montero-Cabezas JM, Greif N, Sánchez-González J, et al. Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy) J Cardiovasc Magn Reson. 2020;22(1):44. doi: 10.1186/s12968-020-00638-8. doi:10.1186/s12968-020-00638-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bratis K, Lindholm A, Hesselstrand R, Arheden H, Karabela G, Stavropoulos E, et al. CMR feature tracking in cardiac asymptomatic systemic sclerosis:Clinical implications. PLoS One. 2019;14(8):e0221021. doi: 10.1371/journal.pone.0221021. doi:10.1371/journal.pone.0221021. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Pakistan Journal of Medical Sciences are provided here courtesy of Professional Medical Publications

RESOURCES